A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Dr.
Neighborhood groups are mobilizing against any proposal that would bring supportive housing and addiction treatment to the campus.
A Massachusetts woman knew the medicine her doctor prescribed required preauthorization, but she didn’t realize the approval had an expiration date. It took nearly three weeks of phone calls and ...
Struggling with depression? NeuroStar TMS at Northeast Health Services offers safe, effective, FDA-cleared, non-drug ...
These health care hurdles can stand in the way of getting treatment your doctor says you need. Here's what to know about how to deal with them.
The Trump administration is proposing Obamacare plans that it says will lower health insurance premiums. But critics warn ...
New AI-Driven Planning Platform Designed to Unlock a New Class of Disease-Modifying Therapies for CNS Disorders MUNICH & REDWOOD CITY, Calif.--(BUSIN ...
The firm is anticipating FDA approval for the bispecific antibody in HER2-positive gastroesophageal cancer this year and advancing the treatment in breast cancer studies.
The assumption that parents of young children need only be offered services and support in order to keep their children safe ...
JURUPA VALLEY, CA - February 13, 2026 - PRESSADVANTAGE - A newly released educational resource provides clinically ...
Plasmalogen precursors for Alzheimer’s are named as first program candidate There are nutrients and dietary compounds ...
President Donald Trump’s unconventional plan to lower prescription drug prices is being met with a skeptical eye from Republicans as Congress places a greater focus on drug pricing ahead of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results